News & Developments

ViewView
Press Releases

King & Spalding Adds Corporate Real Estate Partner Raymond Fang in London to Support UK and European Private Capital Growth

LONDON, May 5, 2026 – King & Spalding announced today that Raymond Fang has joined the firm’s Real Estate and Funds practice group as a partner focused on private capital transactions. He is based in the firm’s London office. Fang is a corporate real estate lawyer who works across the full spectrum of real estate private equity deals, including structured M&A, joint ventures and general partner (GP) stake investments. He advises clients on both UK and cross‑border transactions, ranging from corporate structures holding single-trophy assets to large multi-jurisdictional portfolios. He also advises on strategically significant investments across asset classes such as hospitality and leisure, healthcare, student accommodation, self-storage, living, life sciences, and clean energy infrastructure. “Ray has an impressive blend of both legal and real estate private equity market acumen that is highly complementary to our U.S. platform as well as our international network, including Europe and the Middle East,” said Erik Andersen, co-head of the firm’s Real Estate and Funds practice group. “The firm is investing in the London practice, with corporate real estate an important component of that plan, and Ray’s experience aligns well with those strategic objectives.” Fang joins King & Spalding from Goodwin, where he was a partner. He received his undergraduate and law degree from the University of Sydney. “King & Spalding has been on an impressive trajectory for many years in London and globally, and I’m excited about the opportunity to help grow the firm’s private capital and corporate real estate platform across the UK and Europe,” Fang said. “The strength of the U.S. practice and the firm’s international reach create a compelling foundation for cross-border collaboration.” About King & Spalding King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with 1,300 lawyers in 26 offices in the United States, Europe, the Middle East and Asia Pacific. The firm has handled matters in over 160 countries on six continents and is consistently recognized for the results it obtains, uncompromising commitment to quality, and dedication to understanding the business and culture of its clients. More information is available at www.kslaw.com. Media Contact: Tony Collins +44 7584 613256 [email protected]
King & Spalding - May 21 2026
Press Releases

Walkers advises InSilico Medicine on milestone HKEX IPO listing, driving growth in AI and biotechnology

30 December 2025 Walkers, the international legal and professional services firm, has advised InSilico Medicine Cayman TopCo ("InSilico Medicine"), a reputable AI-driven biotechnology company with global operations, on its successful IPO on the Main Board of the Hong Kong Stock Exchange ("HKEX"), backed by 15 cornerstone investors including Eli Lilly, Tencent and Temasek. The Walkers team, led by partners Andrew Barker and Mark Cummings, and supported by senior associates Beverly Lui and Flora Lo, and associate Samantha Currie, advised on all the Cayman Islands legal aspect of the transaction. The team worked closely with InSilico Medicine's lead counsel Davis Polk & Wardwell to ensure seamless execution across multiple jurisdictions. Accelerating innovation and industry development This listing underscores the development trends in emerging sectors such as AI and biotechnology. It enables InSilico Medicine to advance its clinical pipeline through its proprietary Pharm.ai platform and to invest further in cutting-edge technologies, including generative AI and automated laboratories. InSilico Medicine raised HK$2.277 billion in this IPO, achieving the largest biotech IPO in Hong Kong this year, as in the size of fundraising. Guiding clients through complex, multi-jurisdictional transactions Andrew Barker commented, 'We are proud to have provided ongoing support to InSilico Medicine, particularly in helping it reach this milestone transaction. It highlights investor confidence in emerging sectors and demonstrates our ability to deliver strategic, multi-jurisdictional legal solutions that empower clients to scale globally. Mark Cummings added, 'Our cross-border Corporate team thrives on guiding clients through complex corporate transactions. This successful listing reinforces Walkers’ commitment to delivering innovative, round-the-clock legal advice that helps businesses navigate uncharted waters and seize opportunities in dynamic markets.' Congratulations to everyone involved in this transaction. ENDS ___________________________________________ About Walkers Walkers is a leading international legal and professional services law firm specialising in the law of the global investment hubs Bermuda, BVI, Cayman Islands, Guernsey, Ireland and Jersey. With 10 strategically located offices across the Americas, Asia and Europe and 12 global practice groups, we provide seamless, multi-jurisdictional solutions to financial institutions, capital markets participants, investment fund managers, multinational corporations and family offices. Alongside Walkers' legal offering, we provide corporate and fiduciary services to many of the world's leading private equity and hedge funds, CLO managers, trusts and other financial institutions through Walkers Professional Services (WPS). For more information, contact: Shana Ray Head of Business Development, Asia & Middle East T: +852 9030 6084 E: [email protected]   Jenny Kokolas Communications Manager, Global T +44 (0)7301 272 247 E [email protected]
Walkers - January 5 2026